fbpx

Dr Vanessa Estall

MD BHB MBChB FRANZCR
Radiation Oncologist
Refer a patient

Dr Vanessa Estall is an experienced, detail-oriented radiation oncologist who brings a calm and evidence-based approach to her practice. Dr Estall is committed to delivering world-class cancer treatment to her local community in Geelong as well as bringing her expertise to Icon Cancer Centre Richmond and Freemasons.

Biography

Dr Vanessa Estall completed her Bachelor of Medicine, Bachelor of Surgery degree at the University of Auckland in 1996, and completed specialist training in Sydney prior to achieving fellowship of the Royal Australian and New Zealand College of Radiation Oncology (RANZCR) in 2007. She completed a post-graduate fellowship at Addenbrooke’s Hospital in Cambridge, England in 2009 and was an awarded an MD for her research on novel radiation therapy techniques in the management of CNS tumours.

Dr Estall established her radiation oncology career at Peter MacCallum Cancer Centre, gaining extensive experience in her six-year role as clinical lead radiation oncologist in the Skin/Melanoma Unit, and as an active member of the Cranial Radiosurgery team.  She continues to actively participate in clinical research and is currently recruiting to a number of local and international clinical trials.  Throughout her career she has had an active interest in specialist education, quality improvement and governance, and is the current Chief Accreditation Officer for the RANZCR specialist training program.

Dr Estall is a leading radiation oncologist specialising in the use of highly conformal radiation therapy techniques including cranial radiosurgery, Volumetric Modulated Arc Therapy (VMAT) and Tomotherapy. Her clinical experience covers a broad range of solid tumour malignancies, with special clinical interests in central nervous system (CNS) tumours and skin malignancy including merkel cell carcinoma, melanoma and complex squamous cell carcinoma (SCC).

Affiliations & Memberships

  • Royal Australian and New Zealand College of Radiologists (FRANZCR)
  • Royal College of Radiologist UK (RCR)
  • Trans Tasman Radiation Oncology Group (TROG)
  • European Organisation for Research and Treatent of Cancer (EORTC)
  • Australia and New Zealand Melanoma Trials Group (ANZMTG)
  • Australian Merkel Cell Cancer Interest Group (AMIGOS)

Special Interests

Dr Vanessa Estall accepts referrals for all cancer types, with a special clinical interest in:
  • Brain cancer
  • Central Nervous System (CNS)
  • Melanoma
  • Skin cancer

Icon Locations

Epworth Richmond View centre
Epworth Freemasons View centre

Publications

  • P16-positive lymph node metastases from cutaneous head and neck SCC: no association with high risk HPV or prognosis and implications for the workup of the unknown primary. Lachlan J. McDowell, Richard J. Young, Meredith L. Johnston, Tze-Jian Tan, Stephen Kleid, Chen S. Liu, Mathias Bressel, Vanessa Estall, Danny Rischin, Benjamin Solomon, June Corry. Cancer, 2016; 122 (8), 1201-1208.

     

  • In transit metastases from squamous cell carcinoma. Joyce Ma, Albert Wu, Michael Veness, Vanessa Estall, Angela Hong, Martin Borg, Craig James, Jan Ibbetson, Colin Ooi, Warren Weightman, Ian McColl, Ian Hamann, Noel Grieve, Selim Ozluer, Paul Salmon, Markus Nikitins, Yugesh Caplash, Nicholas Marshall, Timothy Edwards, Ian Patterson, Dinesh Selva, Shyamala Huilgol. Dermatologic Surgery, 2016; 42 (11), 1285 – 1292. 

  • Intensity-modulated radiotherapy plan optimisation for skull base lesions: practical class solutions for dose escalation. Vanessa Estall, David Eaton, K.E. Burton, Sarah J. Jefferies, Rajesh Jena, Neil Burnet. Clinical Oncology, 2010; 22 (4), 313 – 320.

  • Outcomes following management of squamous cell carcinoma of the scalp: A retrospective series of 235 patients treated at the Peter MacCallum Cancer Centre. Vanessa Estall, Angela Allen, Angela Webb, Mathias Bressel, Chris McCormack, John Spillane. Australasian Journal of Dermatology, 2016; 58 (4), 207 – 205.

  • Pattern of relapse after fractionated external beam radiotherapy for meningioma: Experience from Addenbrooke’s hospital. Vanessa Estall, S.J. Treece, Rajesh Jena, Sarah J. Jefferies, K.E. Burton, R.A. Parker, Neil Burnet. Clinical Oncology, 2009; 21 (10), 745 – 752.

View all doctors

Search